Procter & Gamble Hygiene and Health Care Ltd (PGHH) has announced its unaudited financial results for the second quarter ended December 31, 2008. Net Sales of Rs 226.1 crores grew by 17 per cent versus Rs 194.1 crores in the corresponding quarter of last year, according to a company press release.
Profit after tax (PAT) at Rs 47.1 crores registered a growth of 2 per cent over the corresponding quarter of last year.
Talking about the results, Bharat V Patel, chairman, PGHH, said, “Profits for the quarter though are lower primarily due to contracted input cost inflation, weakening rupee and impact of one time extra ordinary charges; we expect this to be corrected in the second half of the year subject to macro-economic environment not deteriorating substantially.”
Further, the company’s health care business scaled up by 15 per cent at Rs 124.2 crores, led by strong growth of VICKS Action 500, VICKS Cough Drops and VICKS Inhaler, added the release.
“We are pleased that our company’s health care and feminine hygiene businesses continue on strong double-digit growth trends. This stands testimony to our relentless focus on understanding and meeting the needs of both the consumer and trade customer. Whisper Choice, Whisper Ultra, Vicks Action 500, Vicks Inhaler, and Vicks Cough Drops are leading this growth momentum which we hope to maintain through the second half of this fiscal,” commented Patel.
Company’s feminine hygiene business also witnessed 18 per cent increase with sales of Whisper at Rs 101.4 crores.
— IndiaRetailing Bureau
